JP2009540314A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540314A5
JP2009540314A5 JP2009514827A JP2009514827A JP2009540314A5 JP 2009540314 A5 JP2009540314 A5 JP 2009540314A5 JP 2009514827 A JP2009514827 A JP 2009514827A JP 2009514827 A JP2009514827 A JP 2009514827A JP 2009540314 A5 JP2009540314 A5 JP 2009540314A5
Authority
JP
Japan
Prior art keywords
statin
standard
lipid
marker
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009514827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540314A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2007/050344 external-priority patent/WO2007144467A1/en
Publication of JP2009540314A publication Critical patent/JP2009540314A/ja
Publication of JP2009540314A5 publication Critical patent/JP2009540314A5/ja
Pending legal-status Critical Current

Links

JP2009514827A 2006-06-12 2007-06-12 筋障害診断方法 Pending JP2009540314A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81260206P 2006-06-12 2006-06-12
US87249506P 2006-12-04 2006-12-04
PCT/FI2007/050344 WO2007144467A1 (en) 2006-06-12 2007-06-12 Diagnostic method for myopathy

Publications (2)

Publication Number Publication Date
JP2009540314A JP2009540314A (ja) 2009-11-19
JP2009540314A5 true JP2009540314A5 (enExample) 2010-07-29

Family

ID=38831439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514827A Pending JP2009540314A (ja) 2006-06-12 2007-06-12 筋障害診断方法

Country Status (4)

Country Link
US (1) US7611902B2 (enExample)
EP (1) EP2029771A4 (enExample)
JP (1) JP2009540314A (enExample)
WO (1) WO2007144467A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137977B2 (en) * 2006-04-24 2012-03-20 Children's Hospital & Research Center At Oakland Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
BR112012018771A2 (pt) * 2010-01-29 2017-06-20 Metanomics Gmbh ''método para dianosticar insuficência cardíaca em um sujeito''
ES2557558T3 (es) * 2010-04-16 2016-01-27 The Johns Hopkins University Composiciones y métodos para caracterizar una miopatía
DK2385374T4 (en) 2010-05-05 2018-04-30 Zora Biosciences Oy LIPIDOMICS BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE
CA2800023A1 (en) * 2010-06-01 2011-12-08 Metanomics Health Gmbh Means and methods for diagnosing pancreatic cancer in a subject
EP3293522A3 (en) * 2010-06-20 2018-05-02 Zora Biosciences OY Lipidomic biomarkers for identification of high-risk coronary artery disease patients
DK2508895T3 (en) * 2011-04-08 2015-10-19 Zora Biosciences Oy BIOMARKERS FOR SENSITIVE DETECTION OF STATIN-INDUCED MUSCLE TOXICITY
JP5980900B2 (ja) * 2011-04-08 2016-08-31 ゾラ バイオサイエンシーズ オサケ ユキチュア スタチン誘発性筋毒性の高感度検出のためのバイオマーカー
US9541565B2 (en) * 2011-04-08 2017-01-10 Zora Biosciences Oy Biomarkers for sensitive detection of statin-induced muscle toxicity
JP6539511B2 (ja) * 2015-06-17 2019-07-03 花王株式会社 運動機能の判定用マーカー
JP2016191718A (ja) * 2016-07-27 2016-11-10 ゾラ バイオサイエンシーズ オサケ ユキチュア スタチン誘発性筋毒性の高感度検出のためのバイオマーカー
RU2641038C1 (ru) * 2017-03-06 2018-01-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Способ диагностики врожденной миопатии центрального стержня

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1417629B1 (en) * 2001-07-06 2008-02-20 Lipomics Technologies, Inc. Generating, viewing, interpreting, and utilizing a quantitative database of metabolites
JP2005512516A (ja) * 2001-09-24 2005-05-12 メルク　エンド　カムパニー　インコーポレーテッド スタチン薬物の組合せのスクリーニング方法および選択方法
CA2459508A1 (en) * 2001-09-24 2003-04-03 Lipomics Technologies, Inc. Methods of using quantitative lipid metabolome data
AU2003225752A1 (en) * 2002-03-12 2003-09-29 Paul S. Phillips Method of diagnosing statin myopathy
CN1723277A (zh) * 2002-12-13 2006-01-18 赛罗哥斯公司 培养基组合物、培养方法和获得的成肌细胞及其应用
US20050037946A1 (en) * 2003-01-13 2005-02-17 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
US20070202518A1 (en) * 2005-11-18 2007-08-30 Genomas, Inc. Physiogenomic method for predicting statin injury to muscle and muscle side effects
WO2007061995A2 (en) * 2005-11-21 2007-05-31 Novartis Ag Biomarkers for statin-induced myopathy or rhabdomyolysis

Similar Documents

Publication Publication Date Title
JP2009540314A5 (enExample)
JP2009538607A5 (enExample)
WO2005052592A3 (en) Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
EP2319941A3 (en) Method and apparatus for correlating levels of biomarker products with disease
EP1662993A4 (en) BIOIMPEDANCE METHOD AND DEVICE
WO2007056560A3 (en) System and method for cytological analysis by raman spectroscopic imaging
CY1119262T1 (el) Αναλυτικες μεθοδοι και συστοιχιες για χρηση στην ταυτοποιηση παραγοντων που επαγουν ευαισθητοποιηση στο ανθρωπινο δερμα
NO20070592L (no) Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring.
FR2872659B1 (fr) Procede et appareil pour une reconstruction directe en imagerie par tomosynthese
EP2608091A3 (en) Diagnostic factor set determination apparatus and method
JP2010506147A5 (enExample)
EP2532748A3 (en) DNA aptamer specifically binding to human cardiac troponin I
SG171691A1 (en) Biomarkers for diagnosing multiple sclerosis, and methods thereof
WO2008154570A3 (en) Method for stimulating saliva production during oral sample collection procedure
EA201391634A1 (ru) Приспособление и метод для неинвазивного сбора содержащего клетки слоя колоректальной слизи и выявления заболеваний
DE502004005226D1 (de) Diagnosestellung von akuten myokardialen, ischämischen erkrankungen durch kombination von markern
JP2007508527A5 (enExample)
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
WO2008017984A3 (en) A method, apparatus, graphical user interface, computer-readable medium, and use for quantification of a structure in an object of an image dataset
JP2012189581A5 (enExample)
EP1955726A4 (en) DISTRIBUTED MEDICAL INTRUMENT FOR PLACEMENT IN THE BODY, METHOD FOR PRODUCING THE MEDICAL INSTRUMENT FOR PLACEMENT IN THE BODY AND DEVICE FOR PRODUCING THE MEDICAL INSTRUMENT FOR PLACEMENT IN THE BODY
EP1929258A4 (en) PHOTOELECTRONIC SPECTROSCOPY DEVICE AND USE METHOD
WO2006067792A3 (en) Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease
EP2527359A3 (en) Diagnostic assay
ITRM20040098A1 (it) Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.